[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8,"_9":10},"actionData","errors","root",{"_105":106,"_107":59},"routes/en-gate",{"_104":59},"en-item-original",{"_11":12},"item",{"_13":14,"_15":16,"_17":18,"_19":18,"_20":-5,"_21":-5,"_22":23,"_24":25,"_26":27,"_28":29,"_30":27,"_31":32,"_33":34,"_35":36,"_37":38,"_39":40,"_41":-5,"_40":42,"_43":-5,"_44":-5,"_45":-5,"_46":47,"_48":49,"_50":-5,"_51":52,"_53":54,"_55":56,"_57":38,"_58":59,"_60":-5,"_61":62,"_63":64,"_65":38,"_66":59,"_67":68},"id","ctp8i1uphsyplpuq86d4zd61h","revision",2,"title","#AACR26 Plenary Session Day2","originalTitle","summary","reason","source",{"_13":98,"_79":99,"_100":101,"_102":38,"_103":-5},"links",{"_95":96,"_68":97},"publishedAt","2026-04-18T23:49:42.000Z","discoveredAt","2026-10-22T11:08:52.472Z","timelineAt","category","opinion","tags",[],"score",60,"selected",false,"channel","x","story",{"_88":89,"_90":49,"_91":-5,"_92":-5,"_93":94},"insight","digest","conferenceAbstracts","readingMode","full","author","anu_iris","language","body",{"_83":-5,"_68":84,"_85":86,"_87":59},"outline",[],"relatedStories",[],"indexable","markdownAvailable",true,"group","conference",{"_77":78,"_79":80,"_81":-5,"_82":-5},"engagement",{"_69":70,"_71":72,"_73":74,"_75":76},"posterIsAuthor","hasTranslation","bodyLanguage","original","heat",5,"likes",4,"replies",0,"reposts",1,"slug","aacr-2026","name","AACR 2026 年会","topic","reading","zh","

#AACR26 Plenary Session Day2
#MinimalResidualDisease in Solid Tumors
Great to see Dr Chris Marine
@lab_marine
from
@vib_ccb

#MRD #Cancerreserch #Oncology #treatmentresistance

@AACR

@MassGenBrigham

@KU_Leuven

@WeillCornell

@PeterMacCC

","zhKind","translation","complete","authorName","Anu R I","handle","avatarUrl","quoted","media",[],"aihot","/items/ctp8i1uphsyplpuq86d4zd61h","https://x.com/anu_iris/status/2045651014687273217","aacr26-floor","AACR 2026 现场信号","kind","x_search","firstParty","iconUrl","ok","changelogVersion","2026-10-23T01:25","enEditionEnabled"]